HB 19-1216 - Limits the Cost of Insulin and Authorizes Insulin-Pricing Study - Colorado Key Vote

Timeline

Related Issues

Stage Details

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

See How Your Politicians Voted

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Vote Smart's Synopsis:

Vote to concur with senate amendments and pass a bill that limits the cost of insulin and authorizes an insulin-pricing study.

Highlights:

 

  • Requires that a carrier that provides coverage for prescription insulin drugs to cap the total amount that a covered person is required to pay for a prescription insulin drug at $100 per 30-day supply (Sec. 2). 

  • Requires the Department of Law to investigate the pricing of prescription insulin drugs and to determine whether additional consumer protections are needed (Sec. 3). 

  • Specifies that this act applies to health coverage plans issued or renewed on or after January 1, 2020, or the date of the official declaration of the vote by the governor, whichever is later (Sec. 5).

  • Appropriates $26,000 to the Department of Regulatory Agencies for use by the Division of Insurance (Sec. 4).

See How Your Politicians Voted

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Vote Smart's Synopsis:

Vote to pass an amended bill that limits the cost of insulin and authorizes an insulin-pricing study.

Highlights:

 

  • Requires that a carrier that provides coverage for prescription insulin drugs to cap the total amount that a covered person is required to pay for a prescription insulin drug at $100 per 30-day supply (Sec. 2). 

  • Requires the Department of Law to investigate the pricing of prescription insulin drugs and to determine whether additional consumer protections are needed (Sec. 3). 

  • Specifies that this act applies to health coverage plans issued or renewed on or after January 1, 2020, or the date of the official declaration of the vote by the governor, whichever is later (Sec. 5).

  • Appropriates $26,000 to the Department of Regulatory Agencies for use by the Division of Insurance (Sec. 4).

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

arrow_upward